SCHEMBL6687119

SCHEMBL6687119

C/C=C(/CC)c1cccc(OCc2ccccc2)c1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ABCB1 P08183 3/20 0.45
ABCG2 Q9UNQ0 1/20 0.45
HTR1A P08908 5/20 0.44
ADRA1D P25100 4/20 0.44
ADRA1A P35348 4/20 0.44
ADRA1B P35368 4/20 0.44
DRD2 P14416 1/20 0.44
LIPE Q05469 1/20 0.43
PTGER1 P34995 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.42
BCHE P06276 2/20 0.42
RXRA P19793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28862953 0.82 NPC1 (0.56) NPC1RAB9AMAPTMAPK1TDP1
SCHEMBL23536856 0.80 PTGER1 (0.60) NPC1RAB9AMAPTMAPK1TDP1
SCHEMBL17912878 0.79 MAPT (0.66) MAPTMAPK1TDP1L3MBTL1ABCB1
SCHEMBL30445162 0.78 HTR1A (0.58) MAPTMAPK1TDP1L3MBTL1ABCB1
SCHEMBL11019947 0.78 HTR1A (0.58) MAPTMAPK1TDP1L3MBTL1ABCB1
SCHEMBL29930885 0.78 NPC1 (0.60) NPC1RAB9APTGER1HPGDSMN1; SMN2
SCHEMBL23611725 0.78 NPC1 (0.60) NPC1RAB9APTGER1HPGDSMN1; SMN2
SCHEMBL6312645 0.76 HTR1A (0.63) NPC1RAB9AMAPTMAPK1TDP1
SCHEMBL23611722 0.76 NPC1 (0.68) NPC1RAB9AMAPTL3MBTL1PTGER1
SCHEMBL29930700 0.76 NPC1 (0.68) NPC1RAB9AMAPTL3MBTL1PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004073638-A2 METHOD OF LOWERING BODY TEMPERATURE WITH (S)-2,3-BENZODIAZEPINES VELA PHARMACEUTICALS, INC. (US) 2004-09-02 WO disclosed